Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis
Titel:
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis
Auteur:
Cortes, J. Calvo, V. Ramírez-Merino, N. O'Shaughnessy, J. Brufsky, A. Robert, N. Vidal, M. Muñoz, E. Perez, J. Dawood, S. Saura, C. Di Cosimo, S. González-Martín, A. Bellet, M. Silva, O.E. Miles, D. Llombart, A. Baselga, J.